BackDeep Medicine Acquisition - Tradeable Rights - Oct 2026 Overview

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Assets

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's total assets is $18M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$18.00M
26.10% YoYΔ $-6.36M vs prior year quarter

Peer trimmed avg / median

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Assets History

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 vs. peers: Total Assets Comparison

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) FAQ

As of the most recent data (June 2026), DMAQR shows a total assets of $18M. That compares with $24M in the prior-year period — down 26.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAQR's total assets is now $18M (was $24M) — a 26.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition - Tradeable Rights - Oct 2026 is outperforming or lagging.

Tracking DMAQR's total assets over time shows whether Deep Medicine Acquisition - Tradeable Rights - Oct 2026 is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $24M in the prior-year period — down 26.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Deep Medicine Acquisition - Tradeable Rights - Oct 2026's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $18M) with ownership activity and broader fundamentals.